Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC
- Alexander Drilon
- , Chao Hua Chiu
- , Yun Fan
- , Byoung Chul Cho
- , Shun Lu
- , Myung Ju Ahn
- , Matthew G. Krebs
- , Stephen V. Liu
- , Thomas John
- , Gregory A. Otterson
- , Daniel S.W. Tan
- , Tejas Patil
- , Rafal Dziadziuszko
- , Erminia Massarelli
- , Takashi Seto
- , Robert C. Doebele
- , Bethany Pitcher
- , Nino Kurtsikidze
- , Sebastian Heinzmann
- , Salvatore Siena
- Cornell University
- Veterans General Hospital-Taipei
- Zhejiang Cancer Hospital
- Yonsei University
- Shanghai Jiao Tong University
- University of Manchester
- Georgetown University
- Peter Maccallum Cancer Centre
- Ohio State University
- Duke-NUS Medical School
- University of Colorado Anschutz Medical Campus
- Medical University of Gdańsk
- City of Hope National Med Center
- National Hospital Organization Kyushu Cancer Center
- F. Hoffmann-La Roche Ltd
- F. Hoffmann-La Roche AG
- Asst Grande Ospedale Metropolitano Niguarda
- University of Milan
Research output: Contribution to journal › Article › peer-review
140
Link opens in a new tab
Scopus
citations